BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/23/2022 6:44:05 AM | Browse: 644 | Download: 1664
 |
Received |
|
2021-09-29 07:44 |
 |
Peer-Review Started |
|
2021-09-29 07:45 |
 |
First Decision by Editorial Office Director |
|
2021-12-02 07:38 |
 |
Return for Revision |
|
2021-12-02 07:38 |
 |
Revised |
|
2021-12-09 13:44 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-02-11 05:50 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-02-13 17:01 |
 |
Articles in Press |
|
2022-02-13 17:01 |
 |
Edit the Manuscript by Language Editor |
|
2022-01-17 00:18 |
 |
Typeset the Manuscript |
|
2022-02-21 13:10 |
 |
Publish the Manuscript Online |
|
2022-02-23 06:44 |
| ISSN |
2218-6204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Efficacy of HA330-II column hemoadsorption in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis combined with liver failure: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qian Gao, Xiao-Wei Xin, Chun Zhao, Yu-Juan Wang, Wei Wang, Yi Yin, Xiao-Ru Wang and You-Peng Jin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Clinical Science and Technology Innovation Scheme of Jinan Province |
202019177 |
| Clinical Science and Technology Innovation Scheme of Jinan Province |
201704071 |
|
| Corresponding Author |
You-Peng Jin, PhD, Chief Doctor, Pediatric intensive care unit, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Huaiyin District , Jinan 250021, Shandong Province, China. jinyp79@sina.cn |
| Key Words |
Hemoadsorption; HA330-II column; Hemophagocytic lymphohistiocytosis; Pediatric; Liver failure; Case report |
| Core Tip |
Hemophagocytic hymphohistiocytosis (HLH) is an often fatal disease. We report an 11-year-old female who was diagnosed with Epstein-Barr virus-HLH and presented with coagulation disorders, liver damage, and respiratory insufficiency. In the present case, initially elevated interleukin (IL)-6, IL-8, IL-10, and interferon-γ levels were reduced to within normal ranges following hemoadsorption with HA330-II, and the patient’s condition gradually improved. HA330-II hemoadsorption has the ability to bridge the patient until chemotherapy can contribute to reduced HLH disease activity. |
| Publish Date |
2022-02-23 06:44 |
| Citation |
Gao Q, Xin XW, Zhao C, Wang YJ, Wang W, Yin Y, Wang XR, Jin YP. Efficacy of HA330-II column hemoadsorption in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis combined with liver failure: A case report. World J Hematol 2022; 9(1): 6-12 |
| URL |
https://www.wjgnet.com/2218-6204/full/v9/i1/6.htm |
| DOI |
https://dx.doi.org/10.5315/wjh.v9.i1.6 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.